Effects of obesity on insulin resistance after total hip arthroplasty: a prospective cohort study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036146

Enrollment

Unknown

Registered

2020-08-21

Start date

2020-08-30

Completion date

Unknown

Last updated

2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the hip, necrosis of femoral head

Interventions

18.5=30:no intervention

Eligibility

Sex/Gender

All

Age

20 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Unilateral initial THA; (2) Preoperative American Society of Anesthesiologists (ASA) grade I-III; (3) No additional glucose and insulin intake during the perioperative period.

Exclusion criteria

Exclusion criteria: (1) Suppurative arthritis, ankylosing spondylitis, and other fractures; (2) Diabetes, poorly controlled hypertension, severe cardiopulmonary disease, liver and kidney dysfunction, malignant tumors, autoimmune or inflammatory diseases.

Design outcomes

Primary

Measure	Time frame
BMI;FPG;FINS, C peptides;Inflammation indexes;	—

Secondary

Measure	Time frame
Fasting time;Joint scores;Perioperative complications;	—

Countries

China

Contacts

Public ContactKang Pengde

West China Hospital, Sichuan University

kangpengde1969@163.com+86 18980601953

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026